Temozolomide resistance in glioblastoma multiforme
Резистентность к темозоломиду при мультиформной глиобластоме
2016-05-11
SCID: 54.1/h6rtzkv9
Discuss with AI
DNA repair pathwayGlioblastoma multiformeO6-methylguanine-DNA methyltransferaseTMZ-resistant cell linesTemozolomide resistance
Figures from the paper
Abstract (AI)
Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas. However, at least 50% of TMZ treated patients do not respond to TMZ. This is due primarily to the over-expression of O 6 -methylguanine methyltransferase (MGMT) and/or lack of a DNA repair pathway in GBM cells. Multiple GBM cell lines are known to contain TMZ resistant cells and several acquired TMZ resistant GBM cell lines have been developed for use in experiments designed to define the mechanism of TMZ resistance and the testing of potential therapeutics. However, the characteristics of intrinsic and adaptive TMZ resistant GBM cells have not been systemically compared. This article reviews the characteristics and mechanisms of TMZ resistance in natural and adapted TMZ resistant GBM cell lines. It also summarizes potential treatment options for TMZ resistant GBMs.
Key Findings
1
At least 50% of patients treated with temozolomide do not respond, indicating substantial therapeutic resistance in glioblastoma and astrocytomas.
2
Both intrinsic resistant cells in established glioblastoma cell lines and experimentally adapted resistant lines are used to study resistance mechanisms and therapies.
3
Potential treatment strategies for temozolomide-resistant glioblastomas are summarized, although the abstract does not specify individual therapies.
4
Temozolomide resistance is primarily associated with MGMT overexpression and/or deficiencies in DNA repair pathways within glioblastoma cells.
5
The review systematically compares characteristics and mechanisms of natural versus acquired temozolomide-resistant glioblastoma cells.
Research Object
Intrinsic and adaptive temozolomide-resistant glioblastoma multiforme cells and cell lines
Research Subject
The characteristics and mechanisms of temozolomide resistance, along with potential treatment options for resistant glioblastomas
Publication Details
Publication Date
2016-05-11
Journal
Publisher
ISSN
Cited by
1224
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest